Table of Contents Author Guidelines Submit a Manuscript

Parkinson’s Disease Dementia

Call for Papers

Parkinson’s disease dementia is a decline in thinking and reasoning that develops in many people living with Parkinson’s disease at least a year after diagnosis. The key brain changes linked to Parkinson’s disease and Parkinson’s disease dementia are abnormal microscopic deposits composed chiefly of alpha-synuclein, a protein found widely in the brain with a normal function not yet known. Causes and risk factors for developing PDD have been reported elsewhere heterogeneously. Outcomes of PDD can progress and vary widely.

In order to have an overall view and scientific examination of PDD, for this special issue, we are interested in original research articles as well as review articles that explore aspects of PDD and its related disorders, clinical presentations, diagnostic biomarkers, and therapeutic outcomes.

Potential topics include but are not limited to the following:

  • Development and examination biomarker to the diagnosis, treatment, and clinical outcome of PDD
  • Risk or protective factors and biomarkers for PD to develop PDD
  • Clinical presentation, measurement, and therapeutic outcome for PDD
  • Differentiated biomarkers between PDD and Lewy body dementia
  • Identifying and examining the therapeutic response of PDD
  • Structure or functional imaging that could reflect or predict the development of PDD

Authors can submit their manuscripts through the Manuscript Tracking System at

Submission DeadlineFriday, 5 October 2018
Publication DateFebruary 2019

Papers are published upon acceptance, regardless of the Special Issue publication date.

Lead Guest Editor

Guest Editors